← Back to Search

Adult patients with AML in complete remission undergoing alloHCT for Acute Myeloid Leukemia (MEASURE Trial)

N/A
Recruiting
Research Sponsored by Center for International Blood and Marrow Transplant Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through up to 3 years post-allohct
Awards & highlights

Summary

Prospective determination of the clinical utility of measurable residual disease (MRD) testing for relapse and survival of patients with acute myeloid leukemia (AML) undergoing allogeneic hematopoietic cell transplantation (alloHCT).

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through up to 3 years post-allohct
This trial's timeline: 3 weeks for screening, Varies for treatment, and through up to 3 years post-allohct for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Cumulative incidence of relapse
Overall Survival
Secondary study objectives
Biology of Relapse - Change in Genetic Profile
Body Weight Changes
Biology of Relapse - HLA Loss
+4 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Adult patients with AML in complete remission undergoing alloHCTExperimental Treatment1 Intervention
Adult patients with AML in complete remission undergoing alloHCT

Find a Location

Who is running the clinical trial?

Center for International Blood and Marrow Transplant ResearchLead Sponsor
38 Previous Clinical Trials
200,192,430 Total Patients Enrolled
National Marrow Donor ProgramOTHER
60 Previous Clinical Trials
201,560 Total Patients Enrolled
Jeffrey Auletta, MDStudy ChairNational Marrow Donor Program
~667 spots leftby Jul 2029
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top